INMED PHARMACEUTICALS INC. (INM) Operating cash flow 2020–2025
INMED PHARMACEUTICALS INC. (INM) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$7.8MFY2025 · since FY2020: -$7.4M → -$7.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$7.8M | -11.2% |
| FY2024 | -$7.0M | +4.1% |
| FY2023 | -$7.3M | +53.3% |
| FY2022 | -$15.6M | -59.2% |
| FY2021 | -$9.8M | -32.8% |
| FY2020 | -$7.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice